m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset

Iberia Pharmaceuticals India Ltd IPO

  • Pre Issue Shares

    1,94,26,770

  • No. of Shares Issued

    64,75,560

  • Pre Issue Equity Amt.

    ₹19.43 Cr

  • DP Filling Date

    September 5, 2026

Iberia Pharmaceuticals India Ltd IPO Timeline

EventDate
Iberia Pharmaceuticals India Ltd IPO Opening Date-
Iberia Pharmaceuticals India Ltd IPO Closing Date -
Basis of Allotment-
Initiation of Refunds-
Credit of Shares to Demat-
Iberia Pharmaceuticals India Ltd IPO Listing Date-

Iberia Pharmaceuticals India Ltd IPO Details

Iberia Pharmaceuticals India Ltd IPO Date-
Iberia Pharmaceuticals India Ltd IPO Face Value-
Iberia Pharmaceuticals India Ltd IPO Price-
Iberia Pharmaceuticals India Ltd IPO Lot Size-
Issue Size-
Fresh Issue-
Offer for Sale-
Issue Type-
Listing At-
QIB Shares Offered-
Retail Shares Offered-
NII (HNI) Shares Offered-
Company PromotersNitin Jain, Rishabh Jain, Saurav Ojha
  • Risks
  • Opportunities
  • Pan-India player with leadership position in West and Central India.
  • Diversified and expanding product portfolio with innovative offerings.
  • Established and scalable distribution network.
  • Robust sourcing capabilities and strategically located manufacturing facilities.
  • Strong liquidity position with a track record of consistent financial performance.
  • Experienced Promoters and senior management team, backed by marquee investors.

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • Capital expenditure towards the procurement of plant & machinery for the establishment of the manufacturing facility in Haryana, India.
  • Repayment of all or a portion of certain outstanding borrowings availed by the Company.
  • Branding and marketing expenses towards enhancing the awareness and visibility of the products and brand.
  • Funding the working capital requirements of the Company.
  • General Corporate Purposes.

Iberia Pharmaceuticals India Ltd IPO Prospectus

Iberia Pharmaceuticals India Ltd IPO Listing Date

BSE Script
NSE Symbol
Listing In-
IPO Price₹-
Face Value-

Company Contact Information

Iberia Pharmaceuticals India Ltd
No.4 Block-C 1st Flr Sector-8Dwarka Bagdola South WestDelhi,New Delhi-110077
Phone: +91 93197 28265
Email: cs@iberiapharmaceuticals.com
Website: www.iberiapharmaceuticals.com

Iberia Pharmaceuticals India Ltd IPO Registrar

Phone:+91 22 62638200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com

Iberia Pharmaceuticals India Ltd IPO Lead Manager(s)

  1. Turnaround Corporate Advisors Pvt Ltd

How to Check the Allotment Status of Iberia Pharmaceuticals India Ltd IPO?

To check the IPO allotment status, follow these steps:

  • Visit the official website of the IPO registrar.
  • Navigate to the IPO Allotment Status page.
  • Select “Iberia Pharmaceuticals India Ltd” from the list of available IPOs.
  • Enter any one of these - PAN Number, Application Number, DP/Client ID.
  • Click on Submit to view your allotment status.
  • Alternatively, you can also check the allotment status on the stock exchange websites such as NSE or BSE.
  • About Iberia Pharmaceuticals India Ltd IPO

    Iberia Pharmaceuticals India Limited was originally incorporated as Satnam Medical Agencies Private Limited' as a private limited company under Companies Act, 1956, dated March 30, 2013, with the Registrar of Companies, Delhi and Haryana. Subsequently, the name of the Company was changed to Iberia Pharmaceuticals India Private Limited' dated September 18, 2023. Thereafter, it was converted into a Public Limited Company and a fresh certificate of Incorporation dated July 15, 2024 was issued by the Central Processing Centre.

    IPOs for Subscription